FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
What Afatinib Is Used For: Afatinib is used to treat metastatic non-small cell lung cancer (NSCLC) that has certain EGFR mutations (exon 19 deletion/exon 21 substitution) as detected by an FDA-approved test. Note: If a drug has been approved for one use, physicians may elect to umore...